Antipsychotics in Pregnancy & Breastfeeding

A Practical, Evidence-Based Guide for Clinical Decision-Making

How to Use This Guide (Built for Busy Clinicians)

This guide is designed for clinicians who need fast, clinically actionable answers at the point of care.

Each antipsychotic is presented in a standardized, high-yield format so you can rapidly assess safety in pregnancy and breastfeeding—without digging through guidelines or primary literature.

Each Pregnancy Chapter Is Structured for Rapid Clinical Decision-Making:

  1. Executive Summary – rapid, high-yield clinical takeaways
  2. Reproductive Safety & Teratogenicity – major malformations and key study data
  3. Fetal & Neonatal Risks – EPS vs sedation patterns, neonatal adaptation
  4. Maternal Metabolic & Obstetric Risks – GDM, weight gain, LGA/SGA risk
  5. Neurodevelopmental Outcomes – long-term data and confounding interpretation
  6. Pharmacokinetics & Dosing – trimester-specific changes and dose considerations
  7. Comparative Clinical Positioning – first-line vs second-line vs avoid
  8. Clinic-Ready Tools – patient scripts and EMR templates
  9. Clinical Pearls – high-yield, practice-changing insights

Goal: Move from uncertainty → confident, evidence-based decisions in minutes, not hours

The following chapters are available for a free preview —explore it to get a feel for the structured, clinic-ready approach used throughout this guide:

  1. Typical Antipsychotics (FGA) in Pregnancy
  2. Aripiprazole in Pregnancy

Antipsychotics in Pregnancy

Quetiapine

Olanzapine

Aripiprazole Free

Lurasidone

Cariprazine

Asenapine

Iloperidone

Cobenfy

Clozapine

Antipsychotics with Breastfeeding (Release Date: May 09, 2026) 

This section does not have any lessons.

Responses

Your email address will not be published. Required fields are marked *